Cardiovascular Surgery Suture Thread

Cardiovascular Surgery Suture Thread Market Outlook

The global cardiovascular surgery suture thread market is projected to reach approximately USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2025 to 2035. The increasing prevalence of cardiovascular diseases, driven by factors such as sedentary lifestyles, unhealthy diets, and an aging population, is a significant growth factor for this market. Additionally, advancements in surgical techniques and technologies, coupled with rising healthcare expenditures, are contributing to the demand for high-quality suture threads. Moreover, the growing preference for minimally invasive surgeries is further fueling the market, as these procedures often require specialized suturing materials that enhance patient recovery and outcomes. The ongoing research and development in suture materials and applications are expected to provide a robust stimulus for market expansion.

Growth Factor of the Market

The cardiovascular surgery suture thread market is primarily driven by the rising incidence of heart-related ailments, which necessitate surgical interventions that require sutures for effective healing and recovery. A significant factor contributing to market growth is the increasing number of surgical procedures performed globally, such as coronary artery bypass grafting and heart valve replacements. Furthermore, advancements in suture technology, including the development of barbed and braided sutures, are improving surgical efficiency and patient outcomes. The shift towards minimally invasive surgical techniques has also been a pivotal factor, as these approaches often rely on specialized sutures to facilitate rapid wound healing and reduce scar tissue formation. The growing awareness among healthcare professionals regarding the importance of using high-quality suture materials is prompting hospitals and surgical centers to invest in better products, further driving market growth.

Key Highlights of the Market

• The cardiovascular surgery suture thread market is expected to witness a CAGR of 6.2% from 2025 to 2035.
• Technological advancements in suture materials are enhancing surgical outcomes and recovery times.
• Increasing prevalence of cardiovascular diseases globally is driving demand for surgical interventions.
• Minimally invasive surgeries are gaining traction, necessitating specialized suture threads.
• Healthcare professionals are increasingly prioritizing high-quality suture materials for better patient care.

By Product Type

Non-absorbable Suture Thread:

Non-absorbable suture threads are extensively used in cardiovascular surgeries due to their durability and long-lasting strength. These sutures are typically made from synthetic materials such as polypropylene and polyester, which resist degradation in the body over time. Their ability to provide constant tensile strength makes them ideal for procedures requiring prolonged support, such as heart valve replacements and coronary bypass surgeries. Additionally, non-absorbable sutures can be left in place indefinitely, allowing for optimal healing in cases where tissue support is critical. Their increasing use in combination with advanced surgical techniques is contributing to the overall growth of the cardiovascular suture market.

Absorbable Suture Thread:

Absorbable suture threads play a crucial role in cardiovascular surgeries where temporary support is needed. Composed of materials such as polysorb and silk, these sutures degrade naturally in the body over time, eliminating the need for removal. They are particularly beneficial in surgeries involving delicate tissues, as they minimize the risk of infection and complications associated with foreign materials. The demand for absorbable sutures is rising, especially in minimally invasive procedures, where reducing the burden on patients is essential. Their biocompatibility and ease of use are making them a preferred choice among surgeons, further propelling this segment's growth in the market.

Monofilament Suture Thread:

Monofilament suture threads are characterized by their single-strand construction, which offers several advantages in cardiovascular surgeries, including reduced friction and infection risk. These sutures are less likely to harbor bacteria compared to braided options, making them suitable for procedures requiring high sterility, such as heart transplants. Their smooth surface allows for easy passage through tissue, enhancing the efficiency of surgical procedures. As the focus on patient safety and surgical precision increases, the preference for monofilament sutures is likely to rise, contributing positively to the overall market dynamics.

Braided Suture Thread:

Braided suture threads are known for their superior knot security and tensile strength, making them ideal for high-stress applications in cardiovascular surgery. These sutures, typically made from multiple strands woven together, provide enhanced handling characteristics and flexibility, which are vital during complex procedures. The increasing complexity of cardiovascular surgeries necessitates the use of reliable and strong sutures, prompting surgeons to opt for braided options. The segment's growth is further supported by continuous innovations in materials and manufacturing processes aimed at improving performance attributes.

Barbed Suture Thread:

Barbed suture threads are a relatively newer innovation in the field, designed to facilitate easier and faster suturing techniques. These sutures feature barbs along their length, which anchor the suture in tissues without the need for knots, streamlining the suturing process and reducing surgical time. This unique design is particularly advantageous in complex cardiovascular surgeries, where efficiency is paramount. The rising adoption of barbed sutures is driven by their ability to enhance surgical outcomes and reduce the risk of complications associated with traditional knot-tying methods, thereby contributing to the overall growth of the market.

By Application

Coronary Artery Bypass Grafting:

Coronary artery bypass grafting (CABG) is one of the most common cardiac surgical procedures, and it requires robust and reliable sutures for optimal outcomes. The use of high-quality suture threads is critical in CABG surgeries, as they need to withstand significant tension and stress during the healing process. Non-absorbable sutures are often preferred in this application due to their strength and longevity. The increasing prevalence of coronary artery diseases globally is driving the demand for CABG procedures, which in turn fuels the growth of the suture thread market.

Heart Valve Surgery:

Heart valve surgeries are performed to repair or replace damaged valves, requiring precision and durability in suture materials. The type of suture utilized can impact the long-term success of the surgery, making it essential for surgeons to choose the most suitable option. Both absorbable and non-absorbable sutures are utilized in this application, with a focus on biocompatibility and strength. The growing number of heart valve procedures, driven by aging populations and increased awareness about cardiac health, is propelling the demand for quality suture threads in this segment.

Aneurysm Repair:

Aneurysm repair surgeries are critical for preventing life-threatening situations, and the choice of suture material is vital for ensuring the integrity of the repair. Strong, non-absorbable sutures are often used in these procedures to provide lasting support to the affected blood vessels. As the incidence of aneurysms rises due to lifestyle factors and increasing life expectancy, the demand for specialized sutures in this application is projected to grow significantly. Surgeons increasingly rely on advanced suturing techniques, further enhancing the need for high-performance suture threads.

Cardiac Tumor Surgery:

Cardiac tumor surgeries, while less common, require highly specialized sutures due to the delicate nature of the tissues involved. The choice of suture thread is critical for minimizing complications and promoting optimal healing. Absorbable sutures are often preferred in this application as they reduce the risk of infection and do not necessitate removal, offering a benefit in postoperative care. The growing awareness of cardiac tumors and advancements in surgical techniques are likely to drive demand for quality sutures in this niche segment.

Heart Transplantation:

Heart transplantation surgeries are among the most complex procedures, requiring meticulous suturing to ensure the success of the transplant. The choice of suture material can significantly influence the healing process and overall outcomes. Surgeons often opt for a combination of absorbable and non-absorbable sutures to address various aspects of the surgery. The increasing number of heart transplants performed, driven by advancements in transplant technology and improved patient management, is propelling the growth of the suture thread market in this application.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for cardiovascular surgical sutures, accounting for a major share of the market. The integration of advanced surgical techniques and high patient volumes necessitates a steady supply of reliable suture materials. Hospitals often collaborate with specialized suppliers to ensure they have access to the latest innovations in suture technology, which is crucial for maintaining high standards of patient care. The increasing number of surgical procedures performed in hospitals is further driving the demand for cardiovascular surgery suture threads in this channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence in the healthcare landscape, offering a range of surgical procedures on an outpatient basis. These centers typically require high-quality sutures to ensure optimal outcomes for patients who undergo cardiovascular surgeries. The growing trend of outpatient surgeries is contributing to an increase in demand for suture threads in ASCs, as they often seek cost-effective and efficient solutions. The convenience and accessibility of ASCs make them a vital distribution channel for cardiovascular surgical sutures.

Specialty Clinics:

Specialty clinics focusing on cardiology and cardiovascular surgeries are another essential distribution channel for suture threads. These clinics often specialize in complex procedures, allowing them to leverage specific suture types tailored to their surgical requirements. The increasing prevalence of cardiovascular diseases and the growing number of specialized clinics are driving the demand for high-quality sutures in this channel. Additionally, these clinics often work closely with suture manufacturers to ensure they have access to the latest advancements in suture technology to enhance patient care.

Online Retailers:

The rise of e-commerce has transformed the distribution landscape for medical supplies, including cardiovascular surgical sutures. Online retailers offer a convenient platform for hospitals and surgical centers to procure high-quality sutures efficiently. The ability to compare products, read reviews, and access a broader range of options makes online retailing an attractive channel. The increased adoption of digital solutions in healthcare procurement is likely to further bolster the growth of this distribution channel, as it enhances accessibility and streamlines the purchasing process for surgical sutures.

Others:

Other distribution channels for cardiovascular surgical sutures may include medical supply distributors, wholesalers, and direct sales by manufacturers. These channels play an essential role in ensuring that healthcare facilities have a steady supply of high-quality sutures for surgical use. While they may not hold the largest market share compared to hospitals and specialty clinics, they are crucial for maintaining efficient supply chains. The growing emphasis on quality and efficiency in healthcare procurement is likely to enhance the role of these additional distribution channels in the cardiovascular suture market.

By Material Type

Polypropylene:

Polypropylene is one of the most commonly used materials for cardiovascular surgical sutures due to its excellent tensile strength and resistance to degradation. This non-absorbable material is ideal for a variety of cardiovascular procedures, providing lasting support and stability to the sutured tissues. Its biocompatibility and low tissue reactivity make polypropylene sutures a preferred choice among surgeons, contributing to their growing adoption in the market. As the demand for high-performance suture materials increases, polypropylene is expected to maintain a significant share in the cardiovascular suture thread market.

Polyester:

Polyester sutures are renowned for their high strength and durability, making them suitable for a range of cardiovascular surgeries. These non-absorbable sutures exhibit excellent knot security, which is critical when performing complex procedures such as heart valve replacements. The versatility and reliability of polyester sutures are driving their demand in the market, particularly in situations where prolonged support is necessary. The ongoing advancements in polyester suture technology are likely to enhance their performance characteristics, further boosting their usage in the cardiovascular segment.

Polysorb:

Polysorb sutures are absorbable sutures that offer a controlled rate of absorption, making them suitable for various cardiovascular applications. The ability to provide temporary support while promoting natural tissue healing is a significant advantage of polysorb sutures. Their biocompatibility and minimal inflammatory response contribute to their increasing adoption in cardiovascular surgeries. As the focus on improving patient outcomes continues, the demand for polysorb sutures is expected to grow, driven by their advantages in facilitating faster recovery and reducing postoperative complications.

PTFE:

PTFE (Polytetrafluoroethylene) sutures are valued for their unique properties, including excellent chemical resistance and low friction. These characteristics make PTFE sutures particularly well-suited for cardiovascular surgeries where minimizing tissue trauma is essential. The non-reactive nature of PTFE minimizes the risk of infection and inflammatory responses, making it a preferred choice for complex procedures. The increasing awareness of the benefits of PTFE sutures is likely to strengthen their presence in the cardiovascular suture market as surgeons seek out materials that enhance patient safety and surgical outcomes.

Silk:

Silk sutures have been used in surgical procedures for centuries and continue to hold relevance in cardiovascular surgeries, particularly for their absorbable qualities. While not as widely used as synthetic options, silk sutures provide excellent handling characteristics and are often employed in delicate procedures where precision is paramount. Their natural origin and ease of use make them a favorable choice in specific surgical contexts. The ongoing exploration of silk's advantages in surgical applications is likely to contribute to its sustained presence in the cardiovascular suture market.

By Region

The North American region is anticipated to dominate the cardiovascular surgery suture thread market, accounting for nearly 40% of the overall market share by 2035. The growth in this region is primarily fueled by the rising prevalence of cardiovascular diseases, along with the increasing number of surgical procedures performed. The presence of advanced healthcare infrastructure, coupled with a strong emphasis on research and development, is supporting the growth of innovative suture technologies. Additionally, the rising healthcare expenditure and the presence of key market players are driving the expansion of the cardiovascular suture market in North America, with a projected CAGR of 6.0% from 2025 to 2035.

Europe is also poised to witness substantial growth, contributing approximately 30% of the global cardiovascular surgery suture thread market by 2035. The region is characterized by a rapidly aging population and an increasing incidence of heart diseases, leading to a higher demand for surgical interventions. The focus on improving patient outcomes and the adoption of minimally invasive surgical techniques are further driving the demand for specialized sutures in this region. The combined factors are expected to propel the European market for cardiovascular suture threads, with a CAGR of 5.5% during the forecast period.

Opportunities

The cardiovascular surgery suture thread market presents several lucrative opportunities, particularly with the continuous advancements in surgical techniques and suture materials. The ongoing development of innovative suture technologies, such as barbed and biodegradable sutures, is creating new avenues for market players to explore. Manufacturers that invest in research and development to improve the performance and biocompatibility of their sutures are likely to gain a competitive edge in the market. Additionally, as the trend towards minimally invasive surgeries continues to evolve, the demand for specialized sutures tailored for these procedures will expand, presenting significant opportunities for growth.

Moreover, the increasing focus on personalized medicine is likely to influence the cardiovascular suture market positively. Tailoring suture materials and sizes to individual patient needs can enhance surgical outcomes and patient satisfaction. It creates a demand for custom solutions that cater to specific surgical applications and patient demographics. As healthcare providers and patients become more aware of the benefits of personalized approaches, companies that offer adaptable and innovative suture solutions will be well-positioned to capitalize on these emerging opportunities.

Threats

While the cardiovascular surgery suture thread market is poised for growth, several threats could impede its progress. One significant concern is the intense competition among manufacturers, which can lead to price wars and reduced profit margins. As numerous companies strive to enter the market, especially with advancements in technology, maintaining product differentiation and quality will be crucial. Additionally, stringent regulations related to medical devices can create barriers to entry for new players, adding pressure to existing companies to comply with evolving standards. This regulatory environment can slow down the pace of innovation, restricting the introduction of new products in the market.

Another potential threat is the rising cost of raw materials used in the production of suture threads. Fluctuations in the prices of materials, such as polymers and textiles, can impact the overall cost of suture production and, in turn, influence pricing strategies. Furthermore, economic downturns or public health crises, such as pandemics, can disrupt supply chains, leading to shortages or delivery delays. These factors combined can pose significant challenges for market players, requiring them to develop robust risk management strategies to navigate potential market disruptions.

Competitor Outlook

• Ethicon, Inc.
• Medtronic plc
• B. Braun Melsungen AG
• Stryker Corporation
• Boston Scientific Corporation
• Teleflex Incorporated
• Abbott Laboratories
• ConMed Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Cardinal Health, Inc.
• Medline Industries, Inc.
• Integra LifeSciences Holdings Corporation
• Hernia Repair Suture, Inc.
• Advanced Medical Solutions Group plc

The competitive landscape of the cardiovascular surgery suture thread market is characterized by a mix of established players and emerging companies. Major companies such as Ethicon and Medtronic dominate the market by offering a comprehensive range of innovative suture products, strong brand recognition, and extensive distribution networks. These companies invest heavily in research and development to launch advanced suture materials that enhance surgical outcomes and address the evolving needs of healthcare providers. Their strong presence in hospitals and surgical centers positions them advantageously within the marketplace, allowing them to maintain a leading share.

Additionally, companies like B. Braun and Stryker are enhancing their product portfolios through strategic acquisitions and partnerships, allowing them to expand their reach and capabilities in the cardiovascular suture market. Their focus on technological innovations and high-quality manufacturing processes ensures they remain competitive in a rapidly evolving industry. Furthermore, these companies are increasingly turning towards sustainable practices and eco-friendly materials to meet the growing demand for environmentally responsible medical solutions, setting them apart in a crowded market.

Emerging companies are also making their mark by targeting niche segments and introducing specialized suture products tailored to specific surgical applications. These companies are leveraging cutting-edge technologies, such as biodegradable materials and advanced coating techniques, to introduce unique suturing solutions that enhance surgical efficiency and patient safety. As competition intensifies, these players are focusing on building strong partnerships with healthcare providers to secure their place in the cardiovascular suture market, paving the way for continued innovation and growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ethicon, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ConMed Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smith & Nephew plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Stryker Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 B. Braun Melsungen AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Teleflex Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hernia Repair Suture, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Zimmer Biomet Holdings, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Advanced Medical Solutions Group plc
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Integra LifeSciences Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cardiovascular Surgery Suture Thread Market, By Application
    • 6.1.1 Coronary Artery Bypass Grafting
    • 6.1.2 Heart Valve Surgery
    • 6.1.3 Aneurysm Repair
    • 6.1.4 Cardiac Tumor Surgery
    • 6.1.5 Heart Transplantation
  • 6.2 Cardiovascular Surgery Suture Thread Market, By Product Type
    • 6.2.1 Non-absorbable Suture Thread
    • 6.2.2 Absorbable Suture Thread
    • 6.2.3 Monofilament Suture Thread
    • 6.2.4 Braided Suture Thread
    • 6.2.5 Barbed Suture Thread
  • 6.3 Cardiovascular Surgery Suture Thread Market, By Material Type
    • 6.3.1 Polypropylene
    • 6.3.2 Polyester
    • 6.3.3 Polysorb
    • 6.3.4 PTFE
    • 6.3.5 Silk
  • 6.4 Cardiovascular Surgery Suture Thread Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Retailers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cardiovascular Surgery Suture Thread Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cardiovascular Surgery Suture Thread market is categorized based on

By Product Type

• Non-absorbable Suture Thread
• Absorbable Suture Thread
• Monofilament Suture Thread
• Braided Suture Thread
• Barbed Suture Thread

By Application

• Coronary Artery Bypass Grafting
• Heart Valve Surgery
• Aneurysm Repair
• Cardiac Tumor Surgery
• Heart Transplantation

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Retailers
• Others

By Material Type

• Polypropylene
• Polyester
• Polysorb
• PTFE
• Silk

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ethicon, Inc.
• Medtronic plc
• B. Braun Melsungen AG
• Stryker Corporation
• Boston Scientific Corporation
• Teleflex Incorporated
• Abbott Laboratories
• ConMed Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Cardinal Health, Inc.
• Medline Industries, Inc.
• Integra LifeSciences Holdings Corporation
• Hernia Repair Suture, Inc.
• Advanced Medical Solutions Group plc